Skip to main content

July 2018, Vol 8, No 7

Strategic planning for oncology practices is more important today than ever before, with the oncology landscape rapidly evolving, driven by complex issues not encountered previously. Read More ›

The incidence of sexual dysfunction in cancer survivors can be high and long lasting, but early discussion, evaluation, and treatment of sexual problems can improve sexual outcomes, reduce emotional distress, and facilitate recovery in survivors. Read More ›

Oncologists often discuss medical marijuana with their patients, and approximately 50% of them are recommending it as a treatment for cancer-related symptoms. However, many oncologists are unsure about the reasons for their recommendations, and whether marijuana will be an effective treatment, according to the results of a recent survey of oncologists regarding their knowledge, practices, and attitudes about medical marijuana. Read More ›

In April 2017, the FDA approved midostaurin (Rydapt) as the first tyrosine kinase inhibitor (TKI) for acute myeloid leukemia (AML) with a specific biomarker, FLT3 mutation, marking the introduction of targeted therapy for this notoriously difficult-to-treat type of leukemia. Read More ›

With healthcare premiums on the rise and out-of-pocket costs skyrocketing, almost every person diagnosed with cancer is at risk for being underinsured, but this threat extends beyond a patient’s bank balance. Read More ›

Cancer care is not cheap, but for young adults with cancer, the cost of care goes far beyond medical bills, according to ­Samantha Watson, MBA, 2-time young adult cancer survivor and Co-Founder and CEO of the Samfund. Few resources in the United States are dedicated specifically to helping patients recover financially from cancer. Read More ›

“It’s the disease of not listening that I am troubled with,” a quote attributed to King Henry IV, kicked off a spirited panel discussion on the importance of incorporating the patient’s voice during treatment. Experts addressed these challenges at the 2018 Association of Community Cancer Centers Annual Meeting & Cancer Center Business Summit on March 16, 2018, in Washington, DC. Read More ›